Table 5 The assessment matrix of six medicines with respect to their performance evaluation factors in terms of PFSs
Performance Index \(\to\) | ||||||||
|---|---|---|---|---|---|---|---|---|
Medicines \(\downarrow\) | \(C_{1}\) | \(C_{2}\) | \(C_{3}\) | \(C_{4}\) | \(C_{5}\) | \(C_{6}\) | \(C_{7}\) | \(C_{8}\) |
\(M_{1}\) | \(\left( {0.2,0.7} \right)\) | \(\left( {0.2,0.6} \right)\) | \(\left( {0.4,0.7} \right)\) | \(\left( {0.5,0.8} \right)\) | \(\left( {0.5,0.6} \right)\) | \(\left( {0.5,0.7} \right)\) | \(\left( {0.1,0.7} \right)\) | \(\left( {0.5,0.8} \right)\) |
\(M_{2}\) | \(\left( {0.4,0.7} \right)\) | \(\left( {0.3,0.9} \right)\) | \(\left( {0.1,0.8} \right)\) | \(\left( {0.4,0.7} \right)\) | \(\left( {0.7,0.7} \right)\) | \(\left( {0.4,0.6} \right)\) | \(\left( {0.4,0.8} \right)\) | \(\left( {0.3,0.6} \right)\) |
\(M_{3}\) | \(\left( {0.2,0.9} \right)\) | \(\left( {0.1,0.8} \right)\) | \(\left( {0.2,0.7} \right)\) | \(\left( {0.4,0.4} \right)\) | \(\left( {0.6,0.7} \right)\) | \(\left( {0.3,0.8} \right)\) | \(\left( {0.2,0.9} \right)\) | \(\left( {0.4,0.7} \right)\) |
\(M_{4}\) | \(\left( {0.1,0.7} \right)\) | \(\left( {0.4,0.7} \right)\) | \(\left( {0.4,0.8} \right)\) | \(\left( {0.2,0.5} \right)\) | \(\left( {0.3,0.7} \right)\) | \(\left( {0.2,0.8} \right)\) | \(\left( {0.3,0.7} \right)\) | \(\left( {0.5,0.5} \right)\) |
\(M_{5}\) | \(\left( {0.1,0.6} \right)\) | \(\left( {0.2,0.9} \right)\) | \(\left( {0.3,0.8} \right)\) | \(\left( {0.4,0.6} \right)\) | \(\left( {0.1,0.8} \right)\) | \(\left( {0.9,0.2} \right)\) | \(\left( {0.8,0.3} \right)\) | \(\left( {0.8,0.4} \right)\) |
\(M_{6}\) | \(\left( {0.3,0.8} \right)\) | \(\left( {0.3,0.6} \right)\) | \(\left( {0.4,0.9} \right)\) | \(\left( {0.1,0.8} \right)\) | \(\left( {0.4,0.7} \right)\) | \(\left( {0.1,0.9} \right)\) | \(\left( {0.2,0.8} \right)\) | \(\left( {0.6,0.7} \right)\) |